Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
about
Waldenstrom's macroglobulinemia: Recent advances in biology and therapyDiagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelinesUpdate on therapeutic options in Waldenström macroglobulinemiaPrognostic value of the International Scoring System and response in patients with advanced Waldenstrom macroglobulinemiaFludarabine in Waldenstrom's macroglobulinemia.Waldenstrom macroglobulinemiaTherapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's MacroglobulinemiaWaldenstrom macroglobulinemia: prognosis and management.Guidelines on the management of Waldenström macroglobulinaemia.How to manage Waldenstrom's macroglobulinemia.Risk stratification in Waldenström macroglobulinemia.Current and future therapeutic approach for Waldenström's macroglobulinemia.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia.Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemia.Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.Low-dose bortezomib and dexamethasone as primary therapy in elderly patients with Waldenstrӧm macroglobulinemia.
P2860
Q28269017-07E21D88-27E9-4081-ADCB-63775F6A43C7Q28290236-C96B61B5-37EF-4DFB-9A60-028DADEBD238Q28304195-201ABF12-85E8-4556-B951-F9A783B9896BQ28307039-E435BBBF-1655-4983-B169-D9B0460D5C1CQ34351916-B6E9964A-3D94-4463-8500-3EC53095C210Q35097328-DAC6207C-D39E-4C3F-B89A-4D9A04BB1489Q35153656-B1154C43-3FBC-4C8C-B308-9A3C942422FFQ35244911-BDD861EA-B419-4346-B163-779F593E2FFBQ36399851-5EDCB0E8-F848-41D3-B1AA-C8D4C07B0A6AQ36764811-DC79D21D-4E84-4B19-B706-8570BC95C891Q37999886-F1857250-23ED-4F7E-96BE-CBFB2AE397F9Q38206820-87AA1BAF-C2FB-4BB9-9254-A2C3C73A09D3Q39044362-14E2B958-74FA-4150-9F86-B7C857E6FDE3Q40773209-37D7476A-1971-4A37-AFEF-FDE74E99CAC4Q42861257-6FDA0DAF-BDA0-47F7-A76F-BC59575B2639Q43078127-B6C9377A-6FE4-4017-93BB-68E5DD6F7C19Q47819332-EA06783A-AB62-409A-9CED-F8916C2D22CC
P2860
Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@en
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@nl
type
label
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@en
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@nl
prefLabel
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@en
Fludarabine plus cyclophospham ...... nemia: results in 49 patients.
@nl
P2093
P2860
P356
P1433
P1476
Fludarabine plus cyclophospham ...... inemia: results in 49 patients
@en
P2093
Chaleteix C
Christian B
Fermand JP
Stalniewicz L
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403885
P577
2005-10-01T00:00:00Z